Cough Suppressant Drugs Market - Frequent approvals and launch of new cough suppressant drugs and high prevalence of cough is expected to drive the market growth

Cough Suppressant Drugs Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the Cough Suppressant Drugs Industry.

Cough Suppressant Drugs Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective business decisions. One of the objectives of this report is to identify the latest developments, market shares, and strategies employed by the major market players. Besides, the least competitive market niches with significant growth potential are also identified. For research methodology, secondary research, primary research, subject matter expert advice, quality check, and final review was utilized.

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2427

A cough is a very common symptom of various upper and lower respiratory tract infections. Cough suppressant drugs, or antitussives, are used to relieve the symptoms of cough. Cough suppressant drugs exerts their effect by inhibiting cough centers located in the brain stem, disrupting the cough reflex arc; although the exact mechanism of action is unknown. Codeine and Dextromethorphan are the two most common cough suppressants that are widely used to treat cough or symptoms of cough. Growth of the cough suppressant drugs market is mainly driven by the increasing prevalence of respiratory disorders worldwide.

According to the World Health Organization (WHO), around 65 million people suffer from chronic obstructive pulmonary disease (COPD) and around three million die from it each year, making it the third leading cause of death worldwide. Coughs can be either acute or chronic. Acute coughs begin suddenly and usually last no more than two to three weeks, while chronic coughs last longer than two to three weeks. Causes of chronic cough include chronic bronchitis smoking, gastroesophageal reflux disease, COPD, allergies, asthma, throat disorders, etc. Thus, with the increasing prevalence of respiratory disorders, the demand for cough suppressant drugs is also increasing with a rapid pace.

For instance, in October 2020, GSK Consumer Healthcare launched Robitussin Naturals, the company’s first-ever line of drug-free products that provide relief from occasional cough. Robitussin Naturals Cough Relief Syrups and Gummies are available now at drugstores nationwide in varieties for both adults and children. Moreover, in June 2020, Aurobindo Pharma (Aurobindo) received three approvals from the U.S. Food and Drug Administration (FDA), including for its generic versions of guaifenesin, fluoxetine, and methotrexate. Guaifenesin is a cough medicine used for more than 60 years which may be combined with a cough suppressant, such as dextromethorphan.

Approvals and launch of such new cough suppressants in the market is expected to propel growth of the cough suppressant drugs market. Furthermore, the emergence of COVID-19 is expected to drive the cough suppressant drugs market growth. Coughing is a tremendously effective way to transmit SARS-CoV-2, the strain of coronavirus that causes COVID-19. According to WHO, worldwide, as of 26 April 2021, there have been 146,841,882 confirmed cases of COVID-19, including 3,104,743 deaths. Furthermore, the cough suppressant drugs market, North America, is witnessing robust growth due to frequent approvals of new cough suppressant drugs by FDA (the Food and Drug Administration).

In March 2018, Perrigo announced that the company has received final approval from the U.S. FDA for the store brand OTC equivalent of Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide extended-release tablets, 1200 mg/60 mg).

Purchase this Premium Report With Discount – https://www.coherentmarketinsights.com/promo/buynow/2427

Major Players Are Operating In This Market Are: Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.

Highlights of the Cough Suppressant Drugs report:

1. A complete backdrop analysis, which includes an assessment of the Cough Suppressant Drugs Market
2. An objective assessment of the trajectory of the market
3. Market segmentation up to the second or third level
4. Reporting and evaluation of recent industry developments
5. Important changes in market dynamics
6. Emerging niche segments and regional markets
7. Historical, current, and projected size of the market from the standpoint of both value and volume
8. Market shares and strategies of key players
9. Recommendations to companies for strengthening their foothold in the market

To conclude, the Cough Suppressant Drugs Market report mentions the key geographies, market landscapes alongside the production and consumption analysis, supply and demand analysis, market growth rate, along with future forecast etc. This report also provides SWOT and PEST analysis, investment feasibility and return analysis. Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.